These findings are in good agreement with clinical data showing that in patients with NSCLC, serum IL-6 is negatively correlated with E-cadherin and positively correlated with the levels of N-cadherin and vimentin in tumor tissues and, consequently, with lymph node and distant metastasis [59]. Here, IL6 is linked to non-small cell lung carcinoma.